The name "coronavirus" refers to a general family of viruses. Two of the earliest human transmissible coronaviruses to be discovered in the mid-20th century are thought to be responsible for a large number of cases of the common cold. This new virus is the seventh coronavirus to be identified in humans, and so far has been simply named 2019-nCoV (2019 novel coronavirus).

Diagnostic Pathology: Open Access is a cutting-edge internationally peer-reviewed journal to endorse the advancement of current knowledge pertaining to clinical studies and scientific investigations and foster discussion in all the relevant aspects of Pathology such as Immunopathology, Virtual Pathology, Tissue based Diagnosis, Immunohistochemistry, Diagnostic Pathology of Infectious Diseases.

The virus is currently informally referred to as the Wuhan coronavirus, in reference to its point of origin, the city of Wuhan in China. The first appearance came in a wave of cases in December 2019. The cases were clustered around people associated with the Huanan Seafood market and were initially labeled as a pneumonia-like illness of unknown origin. As of January 21, 2020, there have been over 400 confirmed cases and nine deaths.

OMICS Group is going to organize a prestigious conference on World Congress on Histopathology & Cytopathology that will take place during August 26-27, 2020 at Kyoto, Japan under the theme analyzing the ubiquity in this area under the theme “Histopathology & Cytopathology”.

Diagnostic Pathology: Open Access has also announced a Special Issue on this theme acknowledging the significance in the Global Scientific Community. The Special Issue is being edited by our honorable Executive Editorial Chair Person Dr. Maria Teresa Mascellino. The Submissions are Open!

Regards,

Matthew Richard
Diagnostic Pathology: Open Access
WhatsApp: +32-2-808-66-57
E-mail id: diagnospathol@pathologyinsights.org